/Investor DB

Bridge Investments — 2020 Investments

2 investments dated 2020 · listed companies and verified rows first · show all

Carawaycarawaytx.comin𝕏May 2020 · $5.3Macquired by Merck

Caraway Therapeutics was a preclinical biopharmaceutical company developing small-molecule therapies modulating lysosomal function to treat neurodegenerative and rare diseases.

BiotechHealthtech

Co-investorsDementia Discovery FundEisai Innovation, Inc.McCarthy CapitalMRL Ventures FundSV Health InvestorsAbbVie+9 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Priori Legal

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.